ALOPECIA AREATA (AA)
Clinical trials for ALOPECIA AREATA (AA) explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA (AA) trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA (AA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to regrow hair in severe alopecia
Disease control CompletedThis early-stage trial tested a drug called IMG-007 in 29 adults with alopecia areata who had lost at least half of their scalp hair. The main goal was to check safety, but researchers also measured hair regrowth using a standard tool. The study is now complete, and results will …
Matched conditions: ALOPECIA AREATA (AA)
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Hair loss gene clue found?
Knowledge-focused CompletedThis study looked at whether a specific gene (NR3C1) that helps control inflammation is linked to alopecia areata, an autoimmune condition that causes hair loss. Researchers compared 120 people with and without the condition to see if gene variations affect disease risk or severi…
Matched conditions: ALOPECIA AREATA (AA)
Sponsor: Benha University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC